211 related articles for article (PubMed ID: 34919284)
1. Activation of microglial GPR109A alleviates thermal hyperalgesia in female lupus mice by suppressing IL-18 and glutamatergic synaptic activity.
Viatchenko-Karpinski V; Kong L; Weng HR
Glia; 2022 Apr; 70(4):634-649. PubMed ID: 34919284
[TBL] [Abstract][Full Text] [Related]
2. Activation of Protease-Activated Receptor-1 Causes Chronic Pain in Lupus-Prone Mice Via Suppressing Spinal Glial Glutamate Transporter Function and Enhancing Glutamatergic Synaptic Activity.
Li F; Li D; Liu J; Tang S; Yan J; Li H; Wan Z; Wang L; Yan X
J Pain; 2023 Jul; 24(7):1163-1180. PubMed ID: 36641029
[TBL] [Abstract][Full Text] [Related]
3. Emerging Molecular and Synaptic Targets for the Management of Chronic Pain Caused by Systemic Lupus Erythematosus.
Weng HR
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612414
[TBL] [Abstract][Full Text] [Related]
4. Chronic pain and impaired glial glutamate transporter function in lupus-prone mice are ameliorated by blocking macrophage colony-stimulating factor-1 receptors.
Yan X; Maixner DW; Li F; Weng HR
J Neurochem; 2017 Mar; 140(6):963-976. PubMed ID: 28072466
[TBL] [Abstract][Full Text] [Related]
5. Deficient AMPK activity contributes to hyperexcitability in peripheral nociceptive sensory neurons and thermal hyperalgesia in lupus mice.
Viatchenko-Karpinski V; Kong L; Weng HR
PLoS One; 2023; 18(7):e0288356. PubMed ID: 37440542
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate kinase isoform M2 impairs cognition in systemic lupus erythematosus by promoting microglial synaptic pruning via the β-catenin signaling pathway.
Lu L; Wang H; Liu X; Tan L; Qiao X; Ni J; Sun Y; Liang J; Hou Y; Dou H
J Neuroinflammation; 2021 Oct; 18(1):229. PubMed ID: 34645459
[TBL] [Abstract][Full Text] [Related]
7. Minocycline, a microglial inhibitor, blocks spinal CCL2-induced heat hyperalgesia and augmentation of glutamatergic transmission in substantia gelatinosa neurons.
Huang CY; Chen YL; Li AH; Lu JC; Wang HL
J Neuroinflammation; 2014 Jan; 11():7. PubMed ID: 24405660
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic neuropsychiatric effect of stress-induced microglial interleukin 12/23 axis in systemic lupus erythematosus.
Abe N; Tarumi M; Fujieda Y; Takahashi N; Karino K; Uchida M; Kono M; Tanaka Y; Hasebe R; Kato M; Amengual O; Arinuma Y; Oku K; Sato W; Tha KK; Yamasaki M; Watanabe M; Atsumi T; Murakami M
Ann Rheum Dis; 2022 Nov; 81(11):1564-1575. PubMed ID: 35817472
[TBL] [Abstract][Full Text] [Related]
9. Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway.
Mao XF; Wu HY; Tang XQ; Ali U; Liu H; Wang YX
J Neuroinflammation; 2019 Apr; 16(1):84. PubMed ID: 30981281
[TBL] [Abstract][Full Text] [Related]
10. Activation of farnesoid X receptor attenuates liver injury in systemic lupus erythematosus.
Lian F; Wang Y; Chen J; Xu H; Yang X; Liang L; Zhan Z; Ye Y; Chen M
Rheumatol Int; 2012 Jun; 32(6):1705-10. PubMed ID: 21431940
[TBL] [Abstract][Full Text] [Related]
11. Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling.
Willemen HLDM; Eijkelkamp N; Wang H; Dantzer R; Dorn GW; Kelley KW; Heijnen CJ; Kavelaars A
Pain; 2010 Sep; 150(3):550-560. PubMed ID: 20609517
[TBL] [Abstract][Full Text] [Related]
12. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
13. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
[TBL] [Abstract][Full Text] [Related]
14. Treatment with lysophosphatidic acid prevents microglial activation and depression-like behaviours in a murine model of neuropsychiatric systemic lupus erythematosus.
Nagata W; Koizumi A; Nakagawa K; Takahashi S; Gotoh M; Satoh Y; Ishizuka T
Clin Exp Immunol; 2023 Apr; 212(2):81-92. PubMed ID: 36718978
[TBL] [Abstract][Full Text] [Related]
15. Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus.
Han X; Xu T; Ding C; Wang D; Yao G; Chen H; Fang Q; Hu G; Sun L
Signal Transduct Target Ther; 2022 Feb; 7(1):50. PubMed ID: 35177587
[TBL] [Abstract][Full Text] [Related]
16. AMPKα1 knockout enhances nociceptive behaviors and spinal glutamatergic synaptic activities via production of reactive oxygen species in the spinal dorsal horn.
Maixner DW; Yan X; Hooks SB; Weng HR
Neuroscience; 2016 Jun; 326():158-169. PubMed ID: 27058143
[TBL] [Abstract][Full Text] [Related]
17. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice.
Nomura A; Noto D; Murayama G; Chiba A; Miyake S
Arthritis Res Ther; 2019 Dec; 21(1):303. PubMed ID: 31888754
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
Zhang X; Wang G; Bi Y; Jiang Z; Wang X
Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317
[TBL] [Abstract][Full Text] [Related]
19. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
20. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
